Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The share-based incentive scheme resolved by the 2022 Annual General Meeting where about 40 members of senior management were offered to acquire up to 150,000 call options on repurchased class B shares has been fully subscribed.
The call options will be transferred at a price of SEK 64.20 per call option, equivalent to the market value according to an external independent valuation, applying the Black-Scholes-model. The redemption price of the call options amounts to SEK 250.07, equivalent to 120 percent of the volume-weighted average of the paid market price for the shares during the period from 6 May 2022 to 20 May 2022, inclusive.
Stockholm, June 29, 2022
AddLife AB (publ)
For further information, please contact:
Kristina Willgård, CEO, AddLife AB, kristina.willgard@add.life,tel. +46 (0)70 510 12 23,
Christina Rubenhag, CFO, AddLife AB, christina.rubenhag@add.lifetel. +46 (0)70 546 72 22.
AddLife is an independent European player in Life Science that offers high-quality products, services and consulting to both the private and public sectors. AddLife has about 2,200 employees in around 85 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 9 billion. AddLife is listed on the NASDAQ Stockholm stock exchange.
This information is such that AddLife AB (publ) is obliged to publish in accordance with Nasdaq Stockholm's Regulations for issuers. The information was submitted for publication on 29 June 2022 at 10:00 CET.